Chitosan solutions and particles: Evaluation of their permeation enhancing potential on MDCK cells used as blood brain barrier model

Artursson, 1994, Effect of chitosan on the permeability of monolayers of intestinal epithelial-cells (Caco-2), Pharm. Res., 11, 1358, 10.1023/A:1018967116988 Borchard, 1996, The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. 3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro, J. Control. Rel., 39, 131, 10.1016/0168-3659(95)00146-8 Borm, 2006, Nanoparticles in drug delivery and environmental exposure: same size, same risks?, Nanomedicine, 1, 235, 10.2217/17435889.1.2.235 de Jong, 2008, Drug delivery and nanoparticles: applications and hazards, Int. J. Nanomed., 3, 133, 10.2147/IJN.S596 Decker, 1988, A quick and simple method for the quantitation of lactate-dehydrogenase release in measurements of cellular cyto-toxicity and tumor necrosis factor (TNF) activity, J. Immunol. Methods, 115, 61, 10.1016/0022-1759(88)90310-9 Furuse, 2001, Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells, J. Cell Biol., 153, 263, 10.1083/jcb.153.2.263 Garberg, 2005, In vitro models for the blood–brain barrier, Toxicol. In Vitro, 19, 299, 10.1016/j.tiv.2004.06.011 Gumbleton, 2001, Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood–brain barrier, J. Pharm. Sci., 90, 1681, 10.1002/jps.1119 Illum, 1994, Chitosan as a novel nasal delivery system for peptide drugs, Pharm. Res., 11, 1186, 10.1023/A:1018901302450 Kotze, 1998, Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2), J. Control. Rel., 51, 35, 10.1016/S0168-3659(97)00154-5 Legrand, 1992, Lactate-dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as marker, J. Biotechnol., 25, 231, 10.1016/0168-1656(92)90158-6 Mao, 2001, Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency, J. Control. Rel., 70, 399, 10.1016/S0168-3659(00)00361-8 McCarthy, 2000, Inducible expression of claudin-1-myc but not occludin-VSV-G results in aberrant tight junction strand formation in MDCK cells, J. Cell Sci., 113, 3387, 10.1242/jcs.113.19.3387 Pan, 2002, Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo, Int. J. Pharm., 249, 139, 10.1016/S0378-5173(02)00486-6 Rao, 1997, Use of chitosan as a biomaterial: studies on its safety and hemostatic potential, J. Biomed. Mater. Res., 34, 21, 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P Schmitz, 2007, Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system, Biomaterials, 28, 524, 10.1016/j.biomaterials.2006.08.017 Shah, 2007, Modulation of ganciclovir intestinal absorption in presence of absorption enhancers, J. Pharm. Sci., 96, 2710, 10.1002/jps.20888 Shah, 2008, In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers, Drug Dev. Industrial Pharm., 34, 279, 10.1080/03639040701655952 Sjo, 2003, Distinct effects of protein kinase C on the barrier function at different developmental stages, Biosci. Rep., 23, 87, 10.1023/A:1025524323842 Smith, 2004, Effect of chitosan on epithelial cell tight junctions, Pharm. Res., 21, 43, 10.1023/B:PHAM.0000012150.60180.e3 Wang, 2005, Evaluation of the MDR-MDCK cell line as a permeability screen for the blood–brain barrier, Int. J. Pharm., 288, 349, 10.1016/j.ijpharm.2004.10.007